Updated: January 14, 2026
How to Help Your Patients Save Money on Cloderm: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Understanding the Cost Landscape for Cloderm
- Strategy 1: Discuss Generic Substitution
- Strategy 2: Proactively Submit Prior Authorizations
- Strategy 3: Direct Patients to Coupon Programs
- Strategy 4: Patient Assistance Programs for Underinsured Patients
- Strategy 5: Mail-Order for Long-Term Patients
- Strategy 6: Use medfinder to Help Patients Find It
- Provider Summary: A Cloderm Cost-Access Checklist
Cloderm's high cash price can be a treatment adherence barrier. Here's a provider's guide to savings programs, prior authorization strategies, and pharmacy tools for clocortolone pivalate in 2026.
Prescribing Cloderm (clocortolone pivalate 0.1% cream) without addressing cost often means your patient won't fill it. With a retail cash price of $350–$450 per tube and widespread insurance step therapy requirements, affordability is a genuine barrier to adherence. This guide walks through the full landscape of savings options you can communicate to your patients.
Understanding the Cost Landscape for Cloderm
The pricing situation for clocortolone pivalate in 2026:
- Retail/AWP: Brand-name Cloderm retails for $350–$450 per tube; $366 average retail (GoodRx data)
- With GoodRx (generic): $88.73 — a 75–76% reduction
- With RxSaver: As low as $70.47 at select pharmacies
- With insurance (covered): $20–$60 copay, depending on tier — but requires step therapy approval at most commercial plans
Strategy 1: Discuss Generic Substitution
Unless you have a specific clinical reason to prescribe brand-name Cloderm (DAW), allowing generic substitution is the most straightforward way to reduce patient cost. Generic clocortolone pivalate 0.1% cream (from Dr. Reddy's and Prasco) is FDA-bioequivalent and typically priced significantly lower. Write the prescription as "clocortolone pivalate 0.1% cream" rather than "Cloderm" and allow generic substitution.
Strategy 2: Proactively Submit Prior Authorizations
Most commercial insurance plans that cover clocortolone pivalate require a prior authorization under step therapy programs. Submitting the PA at the time of prescribing — rather than waiting for the patient to call back after a pharmacy rejection — dramatically improves the patient experience and adherence.
Key documentation elements for a strong PA submission:
- Diagnosis code (e.g., atopic dermatitis L20.9, psoriasis L40.0, contact dermatitis L25.9)
- Names and dates of two previously tried step therapy alternatives (e.g., triamcinolone acetonide 0.1% cream × 30 days, mometasone furoate 0.1% cream × 30 days)
- Reason for Cloderm specifically: excipient intolerances (lanolin, propylene glycol, fragrance), facial use, pediatric use, history of steroid contact dermatitis
- Clinical trial evidence: Cloderm's Day-4 eczema efficacy data and low allergenicity (Category C) profile can strengthen the PA rationale
Strategy 3: Direct Patients to Coupon Programs
For patients paying cash or patients whose insurance won't cover Cloderm even after a PA, prescription discount programs can substantially reduce costs. Include these in your after-visit summary or patient instructions:
- GoodRx (goodrx.com): Generic clocortolone pivalate for approximately $88.73 — best widely available discount card option as of 2026.
- RxSaver (rxsaver.com): Shows prices starting around $70.47 at select pharmacies. Patients can compare against GoodRx.
- WellRx (wellrx.com): Another discount program worth comparing for local pharmacy pricing.
Strategy 4: Patient Assistance Programs for Underinsured Patients
For patients who are uninsured or underinsured and can't afford even coupon pricing, pharmaceutical patient assistance programs (PAPs) may provide the medication at low or no cost. Refer patients to:
- NeedyMeds.org: The most comprehensive PAP database available free to patients and providers. Search by drug name.
- RxAssist.org: Additional PAP directory maintained by Volunteers in Health Care.
- EPI Health (manufacturer): Contact EPI Health, the current Cloderm trademark holder, directly to ask about savings programs or copay assistance.
Strategy 5: Mail-Order for Long-Term Patients
For patients managing chronic dermatoses who require ongoing Cloderm therapy, mail-order pharmacies often provide a lower per-fill cost for 90-day supplies. Many commercial insurance plans (and Medicare Part D) offer reduced cost-sharing for mail-order fills. Writing the prescription for 90-day supply at the outset gives patients this option. Mail-order pharmacies (CVS Caremark, Express Scripts, OptumRx) are also more likely to have clocortolone pivalate in stock reliably.
Strategy 6: Use medfinder to Help Patients Find It
Even once cost is resolved, patients still need to find a pharmacy that has the medication. Refer patients to medfinder for providers — a service that contacts pharmacies near your patient to find which ones can fill the prescription. This removes the call burden from your staff and helps your patient get started on therapy faster.
Provider Summary: A Cloderm Cost-Access Checklist
- Write for generic (clocortolone pivalate) unless clinically contraindicated
- Submit PA proactively for commercial insurance patients
- Include GoodRx or RxSaver information in after-visit summary for cash-pay patients
- Refer eligible patients to NeedyMeds.org for patient assistance
- Consider 90-day supply for chronic skin condition patients with mail-order benefits
- Direct patients to medfinder to locate the medication efficiently
Frequently Asked Questions
Retail cash price for Cloderm is $350–$450 per tube. With a GoodRx coupon for generic clocortolone pivalate, patients can pay as little as $88.73 at participating pharmacies. With insurance after prior authorization approval, copays typically range from $20–$60.
Document the patient's diagnosis, prior failure of two step therapy alternatives (e.g., triamcinolone acetonide and mometasone furoate), clinical rationale for Cloderm specifically (excipient intolerances, facial use, pediatric use, history of steroid contact dermatitis), and any supporting clinical evidence. Submit proactively at the time of prescribing.
Check NeedyMeds.org and RxAssist.org for current patient assistance programs for clocortolone pivalate. Contact EPI Health (the current trademark holder of Cloderm) directly to ask about any savings cards or PAP eligibility criteria.
No. Patients must choose either their insurance or the GoodRx coupon — they cannot be combined at the pharmacy. Advise patients to compare their insurance copay (after PA approval) to the GoodRx price to determine which is lower for their specific situation.
Cloderm is a branded specialty topical corticosteroid with a niche prescribing base. While generics are available, the brand retains a higher price tier. Additionally, its relatively low prescription volume means less competitive pricing pressure at retail. Discount cards reduce this significantly, but brand-name Cloderm remains expensive without coverage.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Cloderm also looked for:
More about Cloderm
35,931 have already found their meds with Medfinder.
Start your search today.





